220 related articles for article (PubMed ID: 1633265)
1. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor.
Lust JA; Donovan KA; Kline MP; Greipp PR; Kyle RA; Maihle NJ
Cytokine; 1992 Mar; 4(2):96-100. PubMed ID: 1633265
[TBL] [Abstract][Full Text] [Related]
2. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R).
Lust JA; Jelinek DF; Donovan KA; Frederick LA; Huntley BK; Braaten JK; Maihle NJ
Curr Top Microbiol Immunol; 1995; 194():199-206. PubMed ID: 7895493
[TBL] [Abstract][Full Text] [Related]
3. The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma.
Fiedler W; Weh HJ; Suciu E; Wittlief C; Stocking C; Hossfeld DK
Leukemia; 1990 Jul; 4(7):462-5. PubMed ID: 1695702
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells.
Hata H; Xiao H; Petrucci MT; Woodliff J; Chang R; Epstein J
Blood; 1993 Jun; 81(12):3357-64. PubMed ID: 8507873
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
Jernberg H; Pettersson M; Kishimoto T; Nilsson K
Leukemia; 1991 Mar; 5(3):255-65. PubMed ID: 1707469
[TBL] [Abstract][Full Text] [Related]
6. Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130.
Diamant M; Rieneck K; Mechti N; Zhang XG; Svenson M; Bendtzen K; Klein B
FEBS Lett; 1997 Jul; 412(2):379-84. PubMed ID: 9256256
[TBL] [Abstract][Full Text] [Related]
7. Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs.
Matthes T; Werner-Favre C; Tang H; Zhang X; Kindler V; Zubler RH
J Exp Med; 1993 Aug; 178(2):521-8. PubMed ID: 8101860
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the IL-6 receptor in human multiple myeloma, an IL-6-related disease.
Rodriguez C; Theillet C; Portier M; Bataille R; Klein B
FEBS Lett; 1994 Mar; 341(2-3):156-61. PubMed ID: 8137932
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism.
Horiuchi S; Koyanagi Y; Zhou Y; Miyamoto H; Tanaka Y; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
Eur J Immunol; 1994 Aug; 24(8):1945-8. PubMed ID: 8056053
[TBL] [Abstract][Full Text] [Related]
10. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.
Wen XY; Stewart AK; Sooknanan RR; Henderson G; Hawley TS; Reimold AM; Glimcher LH; Baumann H; Malek LT; Hawley RG
Int J Oncol; 1999 Jul; 15(1):173-8. PubMed ID: 10375612
[TBL] [Abstract][Full Text] [Related]
11. Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.
de Hon FD; Ehlers M; Rose-John S; Ebeling SB; Bos HK; Aarden LA; Brakenhoff JP
J Exp Med; 1994 Dec; 180(6):2395-400. PubMed ID: 7964514
[TBL] [Abstract][Full Text] [Related]
12. Estimation of interleukin 6 production by reverse transcriptase-polymerase chain reaction in four human myeloma cell lines.
Suzuki A; Takahashi T; Okuno Y; Fukumoto M; Fukui H; Koishihara Y; Ohsugi Y; Ohno Y; Imura H
Leuk Res; 1991; 15(11):1043-50. PubMed ID: 1720489
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of interleukin (IL)-6 receptor gene expression in vitro and in vivo in IL-6 deprived myeloma cells.
Portier M; Lees D; Caron E; Jourdan M; Boiron JM; Bataille R; Klein B
FEBS Lett; 1992 May; 302(1):35-8. PubMed ID: 1587349
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex.
Ringheim GE; Szczepanik AM; Petko W; Burgher KL; Zhu SZ; Chao CC
Brain Res Mol Brain Res; 1998 Mar; 55(1):35-44. PubMed ID: 9645958
[TBL] [Abstract][Full Text] [Related]
15. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
[TBL] [Abstract][Full Text] [Related]
16. Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A; Grande A; Gamberi B; Bonsi L; Fogli M; Amabile M; Cavo M; Ferrari S; Tura S
Br J Haematol; 1994 Dec; 88(4):760-9. PubMed ID: 7529540
[TBL] [Abstract][Full Text] [Related]
17. Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors.
Diamant M; Hansen MB; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
Leuk Res; 1996 Apr; 20(4):291-301. PubMed ID: 8642840
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6: possible implications in human diseases.
Hirano T; Kishimoto T
Ric Clin Lab; 1989; 19(1):1-10. PubMed ID: 2669108
[TBL] [Abstract][Full Text] [Related]
19. C-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A
Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
[TBL] [Abstract][Full Text] [Related]
20. Role of interleukin 6 in the growth of myeloma-derived cell lines.
Barut BA; Zon LI; Cochran MK; Paul SR; Chauhan D; Mohrbacher A; Fingeroth J; Anderson KC
Leuk Res; 1992 Oct; 16(10):951-9. PubMed ID: 1405708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
